Biotech Coverage Rankings

Ordered lists from our own accumulated coverage, story volume, average impact, entity mentions, and high-scored headlines. These ranks describe what we cover, not which companies or products are better. Every figure is a live aggregate; see our editorial methodology for how topics, mentions, and impact scores are derived.

Most-covered topic: Pharma (509 stories). Most-mentioned entity: FDA (70 stories).

Topics by Story Volume

All-time story count per topic across 775 tracked stories. Related: coverage statistics · compare topics.

  1. 1 Pharma
    509
  2. 2 Clinical Trials
    98
  3. 3 FDA Actions
    65
  4. 4 Funding
    59
  5. 5 Acquisitions
    19
  6. 6 Gene & Cell Therapy
    18
  7. 7 IPOs & Funding
    7

Topics by Average Impact

Average editorial impact score (0–10) among topics with at least one story. Volume and consequence are different signals, a quieter topic can outrank a busy one on impact.

  1. 1 Acquisitions 19 stories 6.9/10
  2. 2 Clinical Trials 98 stories 6.6/10
  3. 3 FDA Actions 65 stories 6.6/10
  4. 4 Gene & Cell Therapy 18 stories 6.3/10
  5. 5 Funding 59 stories 6/10
  6. 6 Pharma 509 stories 5.9/10
  7. 7 IPOs & Funding 7 stories 5.6/10

Most-Mentioned Entities

Top 25 by distinct story mentions above our minimum relevance threshold, who our coverage returns to most often, not a quality or recommendation ranking.

  1. 1 FDA organization
    70
  2. 2 Novo Nordisk company
    34
  3. 3 Eli Lilly company
    33
  4. 4 Wall Street Zen company
    18
  5. 5 Pfizer company
    18
  6. 6 Weiss Ratings company
    17
  7. 7 Donald Trump person
    16
  8. 8 GSK company
    16
  9. 9 FDA company
    16
  10. 10 Robert F. Kennedy Jr. person
    13
  11. 11 Moderna company
    12
  12. 12 China country
    11
  13. 13 Novartis company
    10
  14. 14 Artificial Intelligence technology
    10
  15. 15 Bristol Myers Squibb company
    10
  16. 16 CDC organization
    9
  17. 17 AstraZeneca company
    9
  18. 18 Johnson & Johnson company
    9
  19. 19 Merck & Co. company
    9
  20. 20 Roche company
    8
  21. 21 Trump Administration government
    8
  22. 22 HC Wainwright company
    8
  23. 23 AbbVie company
    7
  24. 24 MarketBeat company
    7
  25. 25 World Health Organization organization
    7

Highest-Impact Stories

Fifteen stories with the highest editorial impact scores in this niche (ties broken by newer publish date). Impact weights regulatory, financial, and operational consequence, not headline volume.

  1. 1
    AstraZeneca and BMS in Talks for £300bn Biotech Consolidation Play
    9/10
  2. 2
    AstraZeneca, BMS Eye $400B Union to Build Cancer Powerhouse
    9/10
  3. 3
    Gene-Editing Death Rocks Biotech: Trillion-Virus Trial Under Investigation
    9/10
  4. 4
    Merck’s oral PCSK9 inhibitor hits 59% LDL cut, leapfrogging injectable rivals
    9/10
  5. 5
    Cannabis Rescheduling Could Unlock $2.2B for Biotech & Pharma R&D, Challenger Says
    9/10
  6. 6
    $25M Extortion Bid Exposes Novo Nordisk’s Unreleased Drug Pipeline
    9/10
  7. 7
    $12B Bet on AGI Drug Design: Bezos’s Prometheus Targets Biotech Manufacturing
    9/10
  8. 8
    Geopolitical Conflict in Middle East Threatens Global Pharma Supply Chains
    9/10
  9. 9
    Japan Grants World-First Approval for iPS Stem-Cell Parkinson's Therapy
    9/10
  10. 10
    B.C. Man Cured of Rare Disease in Landmark CRISPR Gene-Editing Success
    9/10
  11. 11
    Ebola's 47.6% CFR in DRC Intensifies Vaccine & Therapeutic Demand
    8/10
  12. 12
    Moderna's mRNA-1010 Approved with 27.4% Efficacy Lead in 65+ Population
    8/10
  13. 13
    As Ebola Deaths Top 1,700, Biotech Races for Bundibugyo Virus Treatments
    8/10
  14. 14
    Bundibugyo Ebola Hits 2,973 Cases, 1,309 Deaths: A Biotech Call to Arms
    8/10
  15. 15
    Bundibugyo Ebola Outbreak at 1,830 Cases Spurs Urgent Clinical Trials
    8/10

How These Rankings Are Computed

Every figure is a live SQL aggregate over Biotech Intelligence Brief's own story and entity tables for this niche, never a syndicated league table or an editor-typed Top-N. Topic ranks use full-population COUNT/AVG; entity ranks count distinct story mentions above the relevance threshold in our methodology. Found a discrepancy? Email hello@getbiobrief.com.

Cite This Page

"Biotech Coverage Rankings." Biotech Intelligence Brief. https://getbiobrief.com/rankings